Clinical Trial Update: Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study evaluating the safety and efficacy of pravastatin in relapsing-remitting multiple sclerosis. The trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: Nantes University Hospital | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 3 | Status: COMPLETED